Shockwave Reducer

Treating the pain of refractory angina is now possible, even if your patient’s discomfort is uncontrollable by traditional medical therapies. Shockwave Reducer is an innovative technology designed to provide much-needed relief to patients suffering from the symptoms of refractory angina by creating a permanent, controlled narrowing of the coronary sinus.*

Coronary Sinus Reduction for Refractory Angina   Shockwave Reducer Overview and MOA
Digital rendering of reducer device
Digital rendering of reducer device

Ingeniously Designed for Angina Treatment

Millions of patients with coronary artery disease (CAD) suffer from refractory angina despite receiving optimal medical therapy, and are not candidates for revascularization. Enter Shockwave Reducer. 

Shockwave Reducer is a small, balloon-expandable, hourglass-shaped device that establishes a narrowing in the coronary sinus. The resulting increase in back pressure reduces angina symptoms by a hypothesized redistribution of blood into the ischemic myocardium.1  

Before Shockwave Reducer, there were limited options for treating refractory angina. Now, an effective, innovative solution is on hand for patients and physicians alike to improve perfusion to ischemic myocardium.

Digitally rendered image of Shockwave Reducer device showing the balloon catheter and the narrow central neck.
How the Shockwave Reducer Works

How Shockwave Reducer Works

See how Shockwave Reducer is implanted in the coronary sinus to help redistribute blood into the ischemic myocardium.

EuroPCR 2024: Relief for the Unrelievable

The latest EuroPCR 2024 symposium included Prof. Stefan Verheye, Prof. Tommaso Gori, Dr. Hakim Benamer, Prof. James Spratt and Prof. Martine Gilard discussing the role of Shockwave Reducer in treating patients suffering from refractory angina. 

The physicians featured are paid consultants for Shockwave Medical. 

See the Impact for Patients

Individual patient stories may vary.

Resources

See All Products

1: Verheye S., et al. N Engl J Med 2015;372:519-27. 

*Shockwave Reducer is commercially available in select European countries and has been implanted in over 3,500 patients. It is currently under clinical investigation in the U.S.

CAUTION: In the United States, Shockwave Reducer is an investigational device, limited by United States law to investigational use. Shockwave Reducer is subject of investigational testing and is being studied in the COSIRA-II trial in Canada. Shockwave Reducer is commercially available in certain countries outside the U.S. and Canada. Please contact your local representative for specific country availability. Prior to use, please reference the Instructions for Use for more information on warnings, precautions and adverse events: ifu.neovasc.com